According to recent studies, CTSB levels in human fluids (serum or plasma) can be measured and remain within the diagnostic window after the onset of the inflammatory bowel diseases (IBD) including Crohn’s disease and Ulcerative colitis, enabling a non-invasive early detection of these diseases [11, 12]. The gene discussed is CTSB; the disease is Crohn disease.